D. Shrager, “Baseline Characteristics of Atopic Dermatitis (AD) and AD Treatments in a Cohort of Adult AD Patients Initiating Dupilumab in a Real-World Registry (PROSE)”, J of Skin, vol. 4, no. 6, p. s106, Oct. 2020.